These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10151016)

  • 41. Early results, complications and restenosis rates after multilesion and multivessel percutaneous transluminal coronary angioplasty.
    Lambert M; Bonan R; Coté G; Crépeau J; de Guise P; Lespérance J; David PR; Waters DD
    Am J Cardiol; 1987 Oct; 60(10):788-91. PubMed ID: 2959138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty.
    Grigg LE; Kay TW; Valentine PA; Larkins R; Flower DJ; Manolas EG; O'Dea K; Sinclair AJ; Hopper JL; Hunt D
    J Am Coll Cardiol; 1989 Mar; 13(3):665-72. PubMed ID: 2537349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibrinogen after coronary angioplasty as a risk factor for restenosis.
    Montalescot G; Ankri A; Vicaut E; Drobinski G; Grosgogeat Y; Thomas D
    Circulation; 1995 Jul; 92(1):31-8. PubMed ID: 7788913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of restenosis after coronary angioplasty: a pharmacological approach.
    Meier B
    Eur Heart J; 1989 Dec; 10 Suppl G():64-8. PubMed ID: 2697565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR).
    Berger PB; Holmes DR; Ohman EM; O'Hanesian MA; Murphy JG; Schwartz RS; Serruys PW; Faxon DP
    J Am Coll Cardiol; 1996 Jan; 27(1):1-7. PubMed ID: 8522681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coronary artery restenosis after balloon angioplasty in humans is associated with circumferential coronary constriction.
    Luo H; Nishioka T; Eigler NL; Forrester JS; Fishbein MC; Berglund H; Siegel RJ
    Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1393-8. PubMed ID: 8911279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Single-center experience with the Palmaz-Schatz intracoronary stent: the immediate results and medium- and long-term follow-up].
    Galassi AR; Tamburino C; Grassi R; Monaco A; Russo G; Ierna SM; Calvi V; Giuffrida G
    Cardiologia; 1996 Nov; 41(11):1097-105. PubMed ID: 9064207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Do fish oils prevent restenosis after coronary angioplasty?
    Leaf A; Jorgensen MB; Jacobs AK; Cote G; Schoenfeld DA; Scheer J; Weiner BH; Slack JD; Kellett MA; Raizner AE
    Circulation; 1994 Nov; 90(5):2248-57. PubMed ID: 7955181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
    Circulation; 1997 Sep; 96(5):1445-53. PubMed ID: 9315530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lesion-to-lesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy. Validation of lesion-based restenosis analysis.
    Gibson CM; Kuntz RE; Nobuyoshi M; Rosner B; Baim DS
    Circulation; 1993 Apr; 87(4):1123-9. PubMed ID: 8462141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ten-year follow-up of percutaneous transluminal coronary angioplasty for proximal left anterior descending coronary artery stenosis in 351 patients.
    Ten Berg JM; Gin MT; Ernst SM; Kelder JC; Suttorp MJ; Mast EG; Bal E; Plokker HW
    J Am Coll Cardiol; 1996 Jul; 28(1):82-8. PubMed ID: 8752798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Silent ischemia after coronary angioplasty: evaluation of restenosis and extent of ischemia in asymptomatic patients by tomographic thallium-201 exercise imaging and comparison with symptomatic patients.
    Hecht HS; Shaw RE; Chin HL; Ryan C; Stertzer SH; Myler RK
    J Am Coll Cardiol; 1991 Mar; 17(3):670-7. PubMed ID: 1993787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting late restenosis after coronary angioplasty by very early (12 to 24 h) thallium-201 scintigraphy: implications with regard to mechanisms of late coronary restenosis.
    Hardoff R; Shefer A; Gips S; Merdler A; Flugelman MY; Halon DA; Lewis BS
    J Am Coll Cardiol; 1990 Jun; 15(7):1486-92. PubMed ID: 2345228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pathophysiology and therapeutic concepts in coronary restenosis].
    Klues HG; Radke PW; Hoffmann R; vom Dahl J
    Herz; 1997 Dec; 22(6):322-34. PubMed ID: 9483438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of coronary stenting on restenosis and occlusion after angioplasty of the culprit vessel in patients with recent myocardial infarction.
    Bauters C; Lablanche JM; Van Belle E; Niculescu R; Meurice T; Mc Fadden EP; Bertrand ME
    Circulation; 1997 Nov; 96(9):2854-8. PubMed ID: 9386149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of a third coronary angioplasty for a second restenosis: short-term results, long-term follow up, and correlates of a third restenosis.
    Tan KH; Sulke N; Taub N; Karani S; Sowton E
    Br Heart J; 1995 Apr; 73(4):327-33. PubMed ID: 7756065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
    Kopp CW; Steiner S; Priglinger U; Christ G; Probst P; Maurer G; Minar E; Huber K
    Blood Coagul Fibrinolysis; 2003 Jun; 14(4):379-86. PubMed ID: 12945880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of endothelial cells in restenosis after coronary angioplasty.
    Meurice T; Vallet B; Bauters C; Dupuis B; Lablanche JM; Bertrand ME
    Fundam Clin Pharmacol; 1996; 10(3):234-42. PubMed ID: 8836697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.